Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +8.00p +0.12% 6,873.00p 6,872.00p 6,874.00p 6,881.00p 6,802.00p 6,818.00p 259,755 10:57:37
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 17,322.1 1,562.8 133.3 50.6 90,158

AstraZeneca to Buy US FDA Priority Review Voucher for $95 Million

22/08/2019 7:58am

Dow Jones News

Astrazeneca (LSE:AZN)
Historical Stock Chart

1 Month : From Aug 2019 to Sep 2019

Click Here for more Astrazeneca Charts.
   By Ian Walker 

AstraZeneca PLC (AZN.LN) said Thursday that it has agreed to buy a U.S. Food and Drug Administration priority review voucher for $95 million from a subsidiary of Swedish Orphan Biovitrum AB (SOBI.SK).

A PRV enables the holder to a FDA priority review of a single new drug application or biologics license application, reducing the target review time and potentially lead to an expedited approval.

The pharmaceutical giant said the acquisition is subject to clearance under the Hart-Scott Rodino Antitrust Improvements Act.


Write to Ian Walker at


(END) Dow Jones Newswires

August 22, 2019 02:43 ET (06:43 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

1 Year Astrazeneca Chart

1 Year Astrazeneca Chart

1 Month Astrazeneca Chart

1 Month Astrazeneca Chart
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190916 10:12:44